Our Science

September 26, 2024 Confronting the World’s Leading Killer with a New Therapeutic Approach For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure. Read More ›
September 12, 2024 RNAi Therapeutics, from Possibility to Patients The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine. Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site